JP6659674B2 - 泡沫形成組成物、及び活性剤を体腔に送達するための方法 - Google Patents

泡沫形成組成物、及び活性剤を体腔に送達するための方法 Download PDF

Info

Publication number
JP6659674B2
JP6659674B2 JP2017516659A JP2017516659A JP6659674B2 JP 6659674 B2 JP6659674 B2 JP 6659674B2 JP 2017516659 A JP2017516659 A JP 2017516659A JP 2017516659 A JP2017516659 A JP 2017516659A JP 6659674 B2 JP6659674 B2 JP 6659674B2
Authority
JP
Japan
Prior art keywords
foam
body cavity
forming
composition
propellant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017516659A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017529377A5 (enExample
JP2017529377A (ja
Inventor
リンダル，オーケ
Original Assignee
ファーミバ エービー
ファーミバ エービー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファーミバ エービー, ファーミバ エービー filed Critical ファーミバ エービー
Publication of JP2017529377A publication Critical patent/JP2017529377A/ja
Publication of JP2017529377A5 publication Critical patent/JP2017529377A5/ja
Application granted granted Critical
Publication of JP6659674B2 publication Critical patent/JP6659674B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2017516659A 2014-09-25 2015-09-25 泡沫形成組成物、及び活性剤を体腔に送達するための方法 Expired - Fee Related JP6659674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462055001P 2014-09-25 2014-09-25
US62/055,001 2014-09-25
PCT/SE2015/051011 WO2016048230A1 (en) 2014-09-25 2015-09-25 Foam-forming compositions and methods for delivering an active agent to a body cavity

Publications (3)

Publication Number Publication Date
JP2017529377A JP2017529377A (ja) 2017-10-05
JP2017529377A5 JP2017529377A5 (enExample) 2018-10-11
JP6659674B2 true JP6659674B2 (ja) 2020-03-04

Family

ID=55581573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017516659A Expired - Fee Related JP6659674B2 (ja) 2014-09-25 2015-09-25 泡沫形成組成物、及び活性剤を体腔に送達するための方法

Country Status (16)

Country Link
US (1) US9895311B2 (enExample)
EP (2) EP3197431B1 (enExample)
JP (1) JP6659674B2 (enExample)
KR (1) KR102569954B1 (enExample)
CN (1) CN106687109B (enExample)
AU (1) AU2015322112B2 (enExample)
BR (1) BR112017006154B1 (enExample)
CA (1) CA2959717C (enExample)
DK (1) DK3197431T3 (enExample)
ES (1) ES2946510T3 (enExample)
FI (1) FI3197431T3 (enExample)
HU (1) HUE062224T2 (enExample)
PL (1) PL3197431T3 (enExample)
PT (1) PT3197431T (enExample)
RU (1) RU2710019C2 (enExample)
WO (1) WO2016048230A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
US20200069630A1 (en) * 2016-07-11 2020-03-05 Hennipen Life Sciences, Llc Compositions for sexually transmitted diseases
CN110785163B (zh) * 2017-05-23 2023-09-05 法尔米瓦股份公司 用于递送活性剂至体腔的泡沫形成组合物
EP4284323A1 (en) 2021-01-27 2023-12-06 Pharmiva AB Composition for use in degradation of biofilm or prevention of biofilm formation
CA3175700A1 (en) * 2021-06-11 2022-12-11 Ankh Life Sciences Limited Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684479A (en) 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
SE454397B (sv) * 1985-12-20 1988-05-02 Biogram Ab Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur
JPH06279228A (ja) 1993-03-30 1994-10-04 Kao Corp 発泡性組成物
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JPH07197083A (ja) 1993-12-28 1995-08-01 Kao Corp 洗浄剤組成物
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5778886A (en) 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2004064833A1 (en) 2003-01-24 2004-08-05 Connetics Australia Pty Ltd. Clindamycin phosphate foam
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US20040197270A1 (en) * 2003-04-01 2004-10-07 Mundschenk David D. Topical formulations and delivery systems
EP1663148A2 (en) * 2003-08-25 2006-06-07 Foamix Ltd. Penetrating pharmaceutical foam
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
EP1768648A1 (en) 2004-04-28 2007-04-04 Foamix Ltd. Body cavity foams
TW200719884A (en) 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
JP2009522003A (ja) * 2005-12-29 2009-06-11 スリーエム イノベイティブ プロパティズ カンパニー 発泡性歯科用組成物及び方法
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
BRPI0809330B8 (pt) * 2007-03-30 2021-05-25 Laccure Ab uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica
ES2382890T3 (es) * 2007-06-19 2012-06-14 Neubourg Skin Care Gmbh & Co. Kg DMS (derma membrane structure) en cremas de espuma.
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8414868B2 (en) * 2010-02-04 2013-04-09 Ultradent Products, Inc. In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions
CA2910114A1 (en) * 2013-04-26 2014-10-30 Bioglan Ab Composition for use in reducing scab formation and promoting healing
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity

Also Published As

Publication number Publication date
EP3197431B1 (en) 2023-03-08
PT3197431T (pt) 2023-05-10
EP3197431A1 (en) 2017-08-02
JP2017529377A (ja) 2017-10-05
WO2016048230A1 (en) 2016-03-31
AU2015322112B2 (en) 2020-10-22
HUE062224T2 (hu) 2023-10-28
BR112017006154B1 (pt) 2024-01-23
DK3197431T3 (da) 2023-06-06
RU2710019C2 (ru) 2019-12-24
KR20170059000A (ko) 2017-05-29
CN106687109B (zh) 2020-10-23
CN106687109A (zh) 2017-05-17
US9895311B2 (en) 2018-02-20
US20160089333A1 (en) 2016-03-31
BR112017006154A2 (en) 2018-02-06
KR102569954B1 (ko) 2023-08-22
EP3197431A4 (en) 2018-04-04
EP4218803A3 (en) 2023-11-01
FI3197431T3 (fi) 2023-05-11
RU2017112055A (ru) 2018-10-25
RU2017112055A3 (enExample) 2019-03-25
CA2959717A1 (en) 2016-03-31
EP4218803A2 (en) 2023-08-02
ES2946510T3 (es) 2023-07-20
CA2959717C (en) 2022-10-18
AU2015322112A1 (en) 2017-03-30
PL3197431T3 (pl) 2023-06-19

Similar Documents

Publication Publication Date Title
US9789057B2 (en) Pharmaceutical delivery system
RU2710019C2 (ru) Пенообразующие композиции и способы доставки активного агента в полость тела
WO2011121604A2 (en) A liquid vaginal spray formulation for treatment of vaginal fungal infection
JP7364556B2 (ja) 体腔に活性物質を送達するための泡形成性組成物
US20240082128A1 (en) Composition for use in degradation of biofilm or prevention of biofilm formation
HK1242202B (en) Foam-forming compositions and methods for delivering an active agent to a body cavity
HK1242202A1 (en) Foam-forming compositions and methods for delivering an active agent to a body cavity
RU2773520C2 (ru) Пенообразующие композиции для доставки активного агента в полость тела
OA18854A (en) Foam-Forming Compositions and Methods for Delivering an Active Agent to a Body Cavity
HK40017987A (en) Foam-forming compositions for delivering an active to a body cavity
HK40017987B (en) Foam-forming compositions for delivering an active to a body cavity
OA20623A (en) Foam-forming compositions for delivering an active to a body cavity.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170321

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180910

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190731

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191028

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200206

R150 Certificate of patent or registration of utility model

Ref document number: 6659674

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees